Washington, D.C. —Boyden Gray PLLC welcomes the U.S. Food & Drug Administration (FDA)’s decision to approve Florida’s Section 804 Importation Program (SIP) Proposal, which will allow the state to import certain prescription drugs from Canada. Trent McCotter and Jared Kelson at Boyden Gray PLLC have advised the Florida Agency for Health Care Administration (AHCA) on obtaining approval of this SIP Proposal and represent the agency in ongoing legal proceedings against the FDA for its years-long delay in issuing a decision in this matter.

Florida projects that importing the prescription drugs in its SIP Proposal from Canada will save between $150 and $200 million each year. The imported drugs will fill the needs of Florida Medicaid recipients, patients at facilities run by the Florida Department of Children and Families, individuals under the care of the Florida Agency for Persons with Disabilities, and patients at country health departments managed by the Florida Department of Health.

We are pleased the FDA finally approved Florida’s SIP Proposal and cleared a pathway to bring affordable prescription drugs to the people of Florida,” said McCotter. 

Boyden Gray PLLC provides clients with strategic counsel, regulatory engagement, and impact litigation on the most difficult issues across law, public policy, and politics. The firm advises clients—including corporations, shareholders, trade associations, and workers—across a range of sectors, including energy, financial services, healthcare, and nonprofit. Its attorneys are all experienced litigators, and the firm regularly represents clients before federal trial and appellate courts, including parties and amici before the Supreme Court of the United States. 


For additional information or more media inquiries, please contact media@boydengray.com.